Journal of Medicinal Chemistry p. 1962 - 1969 (1990)
Update date:2022-08-02
Topics:
Rosenberg, Saul H.
Woods, Keith W.
Sham, Hing L.
Kleinert, Hollis D.
Martin, Donald L.
et al.
Incorporation of nonreactive polar functionalities at the C- and N-termini of renin inhibitors led to the development of a subnanomolar compound (21) with millimolar solubility.This inhibitor demonstrated excellent efficacy and a long duration of action upon intravenous administration to monkeys.While activity was also observed intraduodenally, a comparison of the blood pressure responses indicated low bioavailability.Subsequent experiments in rats showed that, although the compound was absorbed from the gastrointrestinal tract, extensive liver extraction severely limited bioavailability.
View MoreHebei Lead Bio-Chemicals Co., Ltd.
website:http://www.ldbiochem.com
Contact:+86-311-87826503
Address:481, Heping West Road, Shijiazhuang,China
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
Hangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Contact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
Contact:Tel: +86-25-58353800
Address:23 Lijing Road, Nanjing Hi-Tech Zone, Nanjing, Jiangsu, China, 210061
Doi:10.1007/s11172-013-0117-y
(2013)Doi:10.1016/j.molstruc.2003.10.049
(2004)Doi:10.1002/ardp.201200038
(2012)Doi:10.1016/j.molstruc.2009.12.043
(2010)Doi:10.1016/j.tetlet.2010.02.163
(2010)Doi:10.1016/j.jfluchem.2010.11.004
(2011)